Sign Up to like & get
recommendations!
1
Published in 2020 at "International Journal of Hematology"
DOI: 10.1007/s12185-020-02908-8
Abstract: Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) is one of the standard regimens for indolent B-cell non-Hodgkin’s lymphoma (NHL). It is unclear whether the prednisolone (PSL) dosage affects the therapeutic effect or the adverse…
read more here.
Keywords:
indolent cell;
psl day;
prednisolone;
dosage ... See more keywords